(Press-News.org) The use of this test in clinical practice would allow for the avoidance of side effects and the implementation of more effective treatment.
"We've found a way to practice precision medicine with standard chemotherapy," says Geoff Macintyre, a researcher at the Spanish National Cancer Research Centre (CNIO).
The research has been published in the journal Nature Genetics
The test will now be validated in a hospital setting, thanks to a new project funded by the Spanish Ministry for Digital Transformation and Public Service.
Chemotherapy seeks to destroy tumor cells and has been a standard treatment for cancer for decades. However, it doesn't always work. "Chemotherapy is good for some patients, but it's not effective in all cases. Between 20 and 50% of cancer patients don't respond to these drugs," explains Geoff Macintyre , head of the Computational Oncology Group at the Spanish National Cancer Research Centre (CNIO). "These patients will suffer the side effects caused by chemotherapy without any clinical benefit."
The team led by Macintyre, in collaboration with the University of Cambridge and Cambridge-based startup company Tailor Bio, has developed a method that predicts which patients will not respond to commonly used chemotherapy drugs, such as platinum-, taxane- and anthracycline-based chemotherapies.
"We have found a way to turn conventional chemotherapies into precision medicines" says Macintyre. The work is published in Nature Genetics, with CNIO researchers Joe Sneath Thompson and Barbara Hernando, and Tailor Bio’s Laura Madrid as first authors.
“Importantly, our study introduces biomarkers for patient stratification for multiple medicines that were not originally developed as targeted therapies”, say the authors in Nature Genetics.
“Our genomic test quantifies biomarkers for the targeted use of three chemotherapies”, Thompson explains. “This test can be applied to many different types of cancer, and therefore, our results could benefit hundreds of thousands of patients each year.”
Recognizing each tumor through chromosome changes
The method developed by the CNIO team is based on the fact that many tumors accumulate changes in the number of chromosomes in their cells. One consequence, Laura Madrid explains, is that "cancer cells do not have the correct amount of genetic material."
These chromosome changes vary in each tumor, but together they form characteristic patterns, or signatures of chromosomal instability. The study now published develops biomarkers based on these signatures of chromosomal instability.
These biomarkers allow us to "detect in advance which patients are resistant to these treatments so that they can avoid unnecessary side effects", explains Macintyre.
The precise use of chemotherapy benefits not only patients but the healthcare system as well by avoiding the cost of unnecessary treatment and complications related to therapy side effects.
Validated with data from more than 800 patients
Once the biomarkers were developed, the CNIO team tested them in an innovative way: with a simulated trial, that is, with existing patient data. The authors drew on a large amount of data from cancer patients who had already been treated with the chemotherapies.
Specifically, the group worked with data from 840 patients with different types of cancer. "We used data from patients with breast, prostate, ovarian, and sarcoma cancer," Hernando explains. “We were able to demonstrate the efficacy of our resistance biomarkers for three types of chemotherapy: platinum compounds, taxanes, and anthracyclines”. Following the success of this study, work has already begun on developing further tests for targeted therapies to see how widely the technology could be applied.
This study has been made possible thanks to the support of the Carlos III Health Institute, the Ministry of Science and Innovation, Cancer Research UK, and the “la Caixa” Foundation.
Further funding to bring this technology to the clinic
To bring this knowledge to the clinic, the technology must now be validated in a hospital setting.
The group has already received funding for this purpose from the Ministry for Digital Transformation and Public Service. This project, in collaboration with Tailor Bio and the 12 de Octubre University Hospital (H12O), will evaluate the technology's integration into the healthcare system by analyzing existing patient samples. This will demonstrate that the technology is ready for use in clinical trials by 2026.
“Taking a biomarker from the discovery phase to the clinic is rarely easy. But with persistence and collaboration, it's possible to turn a research project into a truly promising technology,” says Macintyre.
Funding for this new validation study has been provided by the European Union through the Recovery and Resilience Facility, NextGenerationEU funds, and the Recovery, Transformation, and Resilience Plan (Component 16, Reform 1), Ministry for Digital Transformation and Public Service.
About the Spanish National Cancer Research Center (CNIO)
The Spanish National Cancer Research Center (CNIO) is a public research center under the Ministry of Science, Innovation and Universities. It is the largest cancer research center in Spain and one of the main ones in Europe. It hosts half a thousand scientists plus support staff, dedicated to improving the prevention, diagnosis and treatment of cancer.
END
Scientists develop test that predicts which patients will not respond to cancer chemotherapy
2025-06-23
ELSE PRESS RELEASES FROM THIS DATE:
Scientists create test to predict chemotherapy resistance in patients
2025-06-23
Cancer Research UK-funded scientists at the University of Cambridge, in collaboration with the Spanish National Cancer Research Centre (CNIO) and Cambridge-based startup Tailor Bio, have created a test which can successfully predict whether cancer will resist common forms of chemotherapy treatment.
It works by looking at changes to the order, structure and number of copies of DNA within the cancer - known as chromosomal instability (CIN) signatures. These signatures are found by reading the full DNA sequence of the tumour and looking for patterns in how the chromosomes are disrupted when compared to normal cells
The ...
Wildfires threaten water quality for up to eight years after they burn
2025-06-23
Years after wildfires burn forests and watersheds, the contaminants left behind continue to poison rivers and streams across the Western U.S. — much longer than scientists estimated.
A new study, published today in Nature Communications Earth & Environment, analyzed water quality in more than 500 watersheds across the Western U.S., and is the first large-scale assessment of post-wildfire quality.
The research was led by scientists from the Cooperative Institute for Research in Environmental Science ...
More effective production of “green” hydrogen with new combined material
2025-06-23
The chemical reaction to produce hydrogen from water is several times more effective when using a combination of new materials in three layers, according to researchers at Linköping University in Sweden. Hydrogen produced from water is a promising renewable energy source – especially if the hydrogen is produced using sunlight.
The production of new petrol and diesel cars will be banned in the EU as of 2035. Electric motors are expected to become increasingly common in vehicles – but they are not suitable for all types of transport.
“Passenger cars can have a battery, but heavy trucks, ships or aircraft cannot use ...
Study reveals processes important for skin cancer aggressiveness and identifies two classes of drugs that may block them
2025-06-23
Researchers have discovered that the most aggressive melanomas, the deadliest form of skin cancer, overactivate two key processes in mitochondria, the components of cells that provide energy. Blocking these pathways with currently available drugs effectively killed melanoma cells. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
By mapping the proteins expressed in 151 tumor and normal skin samples, investigators found that the most aggressive melanomas hyper-activate the ...
Recycled plastics can affect hormone systems and metabolism
2025-06-23
A single pellet of recycled plastic can contain over 80 different chemicals. A new study with researchers from University of Gothenburg and Leipzig shows that recycled polyethylene plastic can leach chemicals into water causing impacts in the hormone systems and lipid metabolism of zebrafish larvae.
The plastic pollution crisis has reached global levels, threatening both planetary and human health, and recycling is proposed as one of the solutions to the plastics pollution crisis. However, as plastics contain thousands of chemical additives and other substances that can be toxic, and these are almost ...
How babies are affected by their mother’s age
2025-06-23
Giving birth to a child after 40 is becoming more and more common – but it can entail an increased risk to the child. A new study based on data from over 300,000 births in Sweden shows that children of older mothers are more often born prematurely or with complications, especially when the mother is 45 years of age or older.
In large parts of the world, women are having children later and later in life. In Sweden, 4.8% of mothers were 40 years of age or older in 2022. Previous research has shown that older mothers differ from younger mothers in several respects such as having a higher BMI, a higher proportion having utilised assisted ...
‘Closed loop’ learning barriers prevent doctors from using life-saving bedside ultrasound
2025-06-23
Many doctors abandon a potentially life-saving medical scanning technology soon after training, because systemic barriers prevent it from becoming part of their routine practice, a study has found.
Point-of-care ultrasound (POCUS) enables doctors to perform rapid bedside scans using a portable device. This can quickly reveal life-threatening problems – including heart failure, fluid in the lungs, or internal bleeding – that can often be treated if identified in time.
Although thousands of doctors in the UK are now trained to use POCUS, research, including the new study, shows that many do not continue to use it in practice after completing ...
Simple blood test predicts cognitive decline in Alzheimer's patients, new study shows
2025-06-22
(Helsinki, Finland, Monday, 23 June 2025) Insulin resistance detected by routine triglyceride-glucose (TyG) index can flag people with early Alzheimer’s who are four times more likely to present rapid cognitive decline, according to new research presented at the European Academy of Neurology (EAN) Congress 2025.1
Neurologists at the University of Brescia reviewed records for 315 non-diabetic patients with cognitive deficits, including 200 with biologically confirmed Alzheimer’s disease. All subjects underwent an assessment of insulin resistance using the TyG index and a clinical follow-up of 3 years. When patients ...
Antimicrobial resistance genes hitch rides on imported seafood
2025-06-22
Highlights:
Resistance to colistin, a potent antibiotic, is on the rise.
In 2016, researchers discovered that colistin resistance could be transferred laterally among microbes.
Researchers have isolated genes that confer colistin resistance from imported seafood purchased from markets in Atlanta, Ga.
The findings suggest imported seafood could promote the spread of transmissible colistin resistance.
Los Angeles, Calif.—Colistin is a potent, last-resort antibiotic, used only to treat people ...
New way to find “aged” cells marks fresh approach for research into ageing
2025-06-21
Tokyo, Japan – Researchers from Tokyo Metropolitan University have created a new way of telling “aged” human cells apart from younger ones using electric fields. While key markers have been found for these “senescent” cells, current methods require biochemical “labels” which are difficult to apply and affect the cells themselves, making them difficult to study. The new method is label-free and less damaging. The team aims to diversify the method, extending it to other cell types.
Ageing starts at the cellular level. As we get older, aged or “senescent” cells accumulate in our body. Not only have ...